Political and economic decisions by key trading partners or competitors can have a major impact on the ability of biotechnology products to be produced and sold competitively. The political stability of key market countries such as China and India could significantly impact agricultural trade. Further escalation of Middle East conflicts could also affect trade. Will the European Union, a decade from now, be increasing access for biotechnology-derived crop varieties and growing them as well? What will be the impacts on the use of transgenic varieties of implementing multilateral agreements, such as the Cartagena Protocol on Biosafety or future agreements under the World Trade Organization?